ENDOMETRIAL EVALUATION IN POST-MENOPAUSAL WOMEN AND IN USERS OF HORMONE REPLACEMENT THERAPY
Keywords:
neoplasms, prevention e control, endometrium, menopause, estrogen replacement therapyAbstract
In post-menopausal women, the endometrium is a frequent site of hyperplasia and carcinomatosis transformations and, considering the progressive increase in women 's life expectancy, there was an increase in the incidence and prevalence of this cancer. In this review, the importance of the endometrial cancer, its clinical aspects, risk factors and the propaedeutic methods for early detection are discussed. The repercussion of decreasing mortality rates in women with endometrial cancer, when a screening program is applied to normal post-menopausal women, is evaluated. Finally, the endometrial evaluation in users of hormone replacement therapy is analyzed.
Downloads
References
ALBUQUERQUE, L.G.T. Valor da histerossonografia na avaliação da cavidade endometrial na mulher com sangramento uterino anormal. Campinas, 1997. 68p. Dissertação (Mestrado em Medicina) — Faculdade de Ciências Médicas, UNICAMP, 1997.
AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS. Carcinoma of endometrium. Int J Gynecol Obstet, Limerick, v.40, n.3, p.255-261, 1993. (Tecnical Bulletin, 162).
ANNUAL report on the results of treatment in gynaecological cancer. J Epidem Biostat, v.3, n.1, p.1-168, 1998.
BOKHMAN, J. V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol, New York, v15, n1, p10-17,1983.
BRASIL. Ministério da Saúde. Instituto Nacional do Câncer. Faculdade de Saúde Pública da Universidade de Säo Paulo. Fundação Ecocentro de São Paulo. Incidência de câncer no município de São Paulo, Brasil, 1983-19881993: tendência no período 1969-1993. Brasília, 1999.103p.
BROWN, F.J., KAMMEYER, S.E. Office gynecologic procedures. Primary Care, Philadelphia, v. 13, n.3, p.493-511, 1986.
DECHERNEY, A.H., PERNOLL, M.L. Current obstetrics and gynecologic: diagnosis and treatment. 8.ed. New Jersey: Prentice-Hall, 1994. 352p.
GOLDSTEIN, S.R. et al. Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol, St. Louis, v. 163, n. 1, p.119-123, 1990.
GRÖNROOS, M. et al. Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension. Cancer, Philadelphia, v. 71, n.4, p. 1279-1288, 1993.
GUSBERG, S.B. Detection and prevention of uterine cancer. Câncer, Philadelphia, v.62, n.8, 1784-1786, 1988.
KURJAK, A. et al. Endometrial carcinoma in postmenopausal women: evalution by transvaginal color Doppler ultrasonography. Am J Obstet Gynecol, St. Louis, v. 169, n.6, p. 1597-1603, 1993.
KURMAN, R.J., KAMINSKI, P.E., NORRIS, H.J. The behavior of endometrial hyperplasia: a long-term study of 'untreated' hyperplasia in 170 patients. Câncer, Philadelphia, v.56, n.2, p.403-412, 1985.
MARQUES, J.A. Câncer do corpo do útero: rastreamento, detecção e diagnostico precoce. In: HALBE, H. W. Tratado de ginecologia. 3.ed. São Paulo : Roca, 2000. p.2207-2211.
PINTO-NETO, A.M. etal. Propedéutica endometrial. Femina, Rio de Janeiro, v.26, n.4, p.295-299, 1998.
TOPPOZADA, M.K. Progesterone challenge test and estrogen assays in menopausal women with endometrial adenomatous hyperplasia. Int J Gynecol Obstet, Limerick, v.26, n. l, p. 115-119, 1988.
